General Partner
Sarah is a serial entrepreneur and a Medical Doctor turned investor, based in Palo Alto, CA.(Silicon Valley)
Sarah is a globally experienced transformational leader with over 15 years of cross-industry knowledge. Founder and a General Partner at 1010VC, an early-stage Bioconvergence fund investing in exceptional founders to advance cure, and unlock the potential of multidisciplinary research and tech bio to advance Healthcare and Medicine. She is a member of The Board of Directors of The Alliance for Artificial Intelligence in Healthcare — (AAIH), a global advocacy organization dedicated to the responsible and ethical adoption of Al/ML in healthcare. She serves on the advisory board of Pepticom, a company that developed a cutting edge AI / ML technology de novo drug design and discovery of peptidomimetic therapeutics and is a member of the board of Public Invention, a non-profit organization dedicated to invent things that help all people. Public invention’s work is in service to nurture humanitarian invention such as developing open source medical devices.
Sarah was formely Managing Director US at BIE, a family office with over $2B under management.
She earned her MD from TSMU and studied entrepreneurship and innovation at Wharton.
LinkedIn: https://www.linkedin.com/in/sarahbkmd
Twitter: @sarahbk @1010vc
Email: [email protected] or [email protected]